Legal Representation
Attorney
John C. Baum, Esq.
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 5, 2009 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Oct 5, 2009 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Mar 4, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 4, 2009 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Mar 4, 2009 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Aug 29, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 29, 2008 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Aug 29, 2008 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Mar 3, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 3, 2008 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 3, 2008 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Sep 4, 2007 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 12, 2007 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 23, 2007 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Apr 9, 2007 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Apr 9, 2007 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Mar 16, 2007 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 16, 2007 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 16, 2007 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 16, 2007 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 15, 2007 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Nov 14, 2006 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals and therapeutic preparations for the treatment and prevention of metabolic diseases, disorders, and conditions
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Medical devices for injection and infusion, namely hypodermic injectors and infusion pumps for pharmaceuticals and therapeutics for the treatment and prevention of metabolic diseases, disorders, and conditions
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
010
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"GLUCAGON"